ELOXX PHARMACEUTICALS LTD has a total of 37 patent applications. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GLYCIM OY, YOUNGENE THERAPEUTICS CO LTD and BIOTA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | Canada | 4 | |
#5 | Australia | 3 | |
#6 | Brazil | 3 | |
#7 | China | 3 | |
#8 | Hong Kong | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Baasov Timor | 27 |
#2 | Tuvia Shmuel | 15 |
#3 | Palidi Ravinder | 6 |
#4 | Belakhov Valery | 6 |
#5 | Firzon Vera | 6 |
#6 | Mizhiritskii Michael | 6 |
#7 | Kotala Mani Bushan | 6 |
#8 | Pelled Dori | 5 |
#9 | Eylon Bat-Hen | 5 |
#10 | Timor Baasov | 2 |
Publication | Filing date | Title |
---|---|---|
KR20200024824A | Aminoglycoside derivatives and their use in treating genetic disorders | |
AU2018235441A1 | Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof | |
CN108350014A | Aminoglycoside derivative and its application in treating hereditary conditions | |
WO2017037717A1 | Aminoglycoside derivatives and uses thereof in treating genetic disorders | |
WO2017118968A1 | Aminoglycoside derivatives and uses thereof in treating genetic disorders | |
WO2017037718A1 | Aminoglycoside derivatives and uses thereof in treating genetic disorders | |
WO2015186134A1 | Use of aminoglycoside analogs in the treatment of rett syndrome |